PharmaEngine, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 245.94 million compared to TWD 154.88 million a year ago. Net income was TWD 80.78 million compared to TWD 87.46 million a year ago. Basic earnings per share from continuing operations was TWD 0.56 compared to TWD 0.61 a year ago. Diluted earnings per share from continuing operations was TWD 0.56 compared to TWD 0.61 a year ago.
For the nine months, sales was TWD 580.35 million compared to TWD 495.91 million a year ago. Net income was TWD 237.28 million compared to TWD 265.17 million a year ago. Basic earnings per share from continuing operations was TWD 1.65 compared to TWD 1.85 a year ago. Diluted earnings per share from continuing operations was TWD 1.65 compared to TWD 1.85 a year ago.